BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia Q, Meng Z, Xu K, He X, Tan J, Zhang G, Li X, Liu N, Hu T, Zhou P, Wang S, Upadhyaya A, Liu X, Wang H, Zhang C. Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody. Sci Rep 2017;7:43516. [PMID: 28240744 DOI: 10.1038/srep43516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Riley AS, Mckenzie GAG, Green V, Schettino G, England RJA, Greenman J. The effect of radioiodine treatment on the diseased thyroid gland. International Journal of Radiation Biology 2019;95:1718-27. [DOI: 10.1080/09553002.2019.1665206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Raffat MA, Hadi NI, Hosein M, Zubairi AM, Ikram S, Akram Z. Differential expression of salivary S100A7 in oral submucous fibrosis. Saudi Dent J 2019;31:39-44. [PMID: 30705567 DOI: 10.1016/j.sdentj.2018.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu X, Huang Z, He X, Zheng X, Jia Q, Tan J, Fan Y, Lou C, Meng Z. Blood prognostic predictors of treatment response for patients with papillary thyroid cancer. Biosci Rep 2020;40:BSR20202544. [PMID: 33015713 DOI: 10.1042/BSR20202544] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Weckbach LT, Preissner KT, Deindl E. The Role of Midkine in Arteriogenesis, Involving Mechanosensing, Endothelial Cell Proliferation, and Vasodilation. Int J Mol Sci 2018;19:E2559. [PMID: 30158425 DOI: 10.3390/ijms19092559] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
5 Zhou L, Jiang J, Fu Y, Zhang D, Li T, Fu Q, Yan C, Zhong Y, Dionigi G, Liang N, Sun H. Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules. Diagn Pathol 2021;16:92. [PMID: 34689799 DOI: 10.1186/s13000-021-01150-y] [Reference Citation Analysis]
6 Upadhyaya A, Meng Z, Wang P, Zhang G, Jia Q, Tan J, Li X, Hu T, Liu N, Zhou P, Wang S, Liu X, Wang H, Zhang C, Zhao F, Yan Z. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer. Medicine (Baltimore) 2017;96:e7164. [PMID: 28640094 DOI: 10.1097/MD.0000000000007164] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
7 Li N, Zhang C, Meng Z, Xu K, He X, Yu Y, Jia Q, Li X, Liu X, Wang X. Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer. Medicine (Baltimore) 2018;97:e12242. [PMID: 30200153 DOI: 10.1097/MD.0000000000012242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
8 Sun D, Zheng X, He X, Huang C, Jia Q, Tan J, Zheng W, Li N, Wang P, Wang R, Liu M, Zhao L, Yuan S, Meng Z, Fan Y. Prognostic value and dynamics of antithyroglobulin antibodies for differentiated thyroid carcinoma. Biomark Med 2020;14:1683-92. [PMID: 33346697 DOI: 10.2217/bmm-2019-0432] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Jiang Y, Jin J, Fan J, Huang C, Jia Q, Tan J, He X, Zheng X, Zhao Y, Zhang Q, Meng Z, Wang Y. Urinary iodine concentration and radioactive iodine therapeutic response in patients with differentiated thyroid cancer. Biomark Med 2021;15:879-90. [PMID: 34241549 DOI: 10.2217/bmm-2020-0745] [Reference Citation Analysis]